Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases

Springer Seminars in Immunopathology

Volumn 26, Issue 1-2, 2004, Pages 155-168

  Aversa, Franco ^a   Martelli, Massimo F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acute leukemia; Hematopoietic stem cells; HLA mismatched transplant; NK cell alloreactivity; T cell depletion

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ALLOIMMUNITY; AUTOMATION; B LYMPHOCYTE; BLOOD CELL; BLOOD TOXICITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CELL COUNT; CLINICAL OBSERVATION; DONOR; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INCIDENCE; INFUSION; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NATURAL KILLER CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TIME; TREATMENT INDICATION; UMBILICAL CORD BLOOD;

ACUTE DISEASE; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; LEUKEMIA; LYMPHOCYTE DEPLETION; RECURRENCE; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 11144325816     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-004-0161-7     Document Type: Review

References (73)

1. Alpdogan O, Muriglan SJ, Eng JM, et al (2003) IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112:1095
2. Anasetti C, Beatty PG, Storb R, et al (1990) Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 29:79
3. Anasetti C (2004) Unrelated donor hematopoietic stem cell transplantation. In: Atkinson K, Champlin R, Ritz J, et al (eds) Clinical bone marrow and blood stem cell transplantation. Cambridge University press, Cambridge, pp1029-1056
4. Appelbaum FR (1997) Allogeneic hematopoietic stem cell transplantation for acute leukemia. Semin Oncol 24:114
5. Aversa F, Tabilio A, Terenzi A, et al (1994) Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948
6. Aversa F, Tabilio A, Velardi A, et al (1998) Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:1186
7. Aversa F, Terenzi A, Carotti A, et al (1999) Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. J Clin Oncol 17:1545
8. Aversa F (2002) Hematopoietic stem cell transplantation from full-haplotype mismatched donors. Transfus Apheresis Sci 27:175
9. Bachar-Lustig E, Rachamim N, Li HW, et al (1995) Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1:1268
10. Bachar-Lustig E, Li HW, Gur H, et al (1999) Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by sca- 1(+)Lin(-) bone marrow progenitor cells: synergism with non- alloreactive (Host x Donor)F(1) T cells. Blood 94:3212
11. Beatty PG, Mori M, Milford E (1995) Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 60:778
12. Burnett AK (2002) Acute myeloid leukemia: Treatment of adults under 60 years. Rev Clin Exp Hematol 6:26
13. Cavazzana-Calvo M, Stephan JL, Sarnacki S, et al (1994) Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood 83:288
14. Cobbold SP, Martin G, Quin S, et al (1986) Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164
15. Cunningham I, Aversa F, Martelli MF (1997) Making successful haplotype-mismatched transplants possible. Forum 72:203
16. Davison GM, Novitzky N, Kline A, et al (2000) Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells. Transplantation 69:1341
17. Di Ianni M, Sportoletti P, Del Papa B, et al (2004) Human stromal cells engineered with interleukin-7 enhance the survival of naive T-lymphocytes. Abstracts of the 30th Annual Meeting of the European Group for Blood and Marrow Transplantation, Barcelona 28-31 March 2004. Abstr O279
18. Dumont-Girard F, Roux E, Lier RA van, et al (1998) Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92:4464
19. Gluckman E (2001) Hematopoietic stem cell transplant using umbilical cord blood. N Engl J Med 344:1860
20. Gluckman E, Rocha V (2004) Umbilical cord blood transplantation. In: Atkinson K, Champlin R, Ritz J, et al (eds) Clinical bone marrow and blood stem cell transplantation. Cambridge University press, Cambridge, pp1057-1074
21. Godder KT, Hazlett LJ, Abhyankar SH et al (2000) Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome. J Clin Oncol 18:1856
22. Greenwald RJ, Boussiotis VA, Lorsbach RB, et al (2001) CTLA-4 regulates induction of anergy in vivo. Immunity 14:145
23. Grewal SS, Barker JN, Davies SM, Wagner JE (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101:4233
24. Gribben JG, Guinan EC, Boussiotis VA, et al (1996) Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. Blood 87:4887
25. Guinan EC, Boussiotis VA, Neuberg D, et al (1999) Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340:1704
26. Gur H, Krauthgamer R, Berrebi A, et al (2002) Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood 99:4174
27. Handgretinger R, Schumm M, Lang P, et al (1999) Transplantation of megadoses of purified haploidentical stem cells. Ann NY Acad Sci 872:351
28. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27:777
29. Hansen JA, Petersdorf E, Martin PJ, et al (1997) Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 157:141
30. Heitger A, Greinix H, Mannhalter C, et al (2000) Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 69:2366
31. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al (1987) Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 89:3864
32. Horowitz MM, Gale RP, Sondel PM, et al (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 7:555
33. Kernan NA, Flomemberg N, Dupont B, et al (1987) Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia: identification of host derived anti-donor allocytotoxic T lymphocytes. Transplantation 43:482
34. Kernan NA, Kartsch G, Ash RC, et al (1993) Analysis of 462 transplantation from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593
35. Klingebiel T, Lang P, Scumm M, et al (2001) Current results in haploidentical cell transplantation in children. Hematol J 1:324
36. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359
37. Lapidot T, Singer TS, Salomon O, et al (1988) Booster irradiation to the spleen following total body irradiation: a new immunosuppressive approach for allogeneic bone marrow transplantation. J Immunol 141:2619
38. Lapidot T, Terenzi A, Singer TS, et al (1989) Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 73:2025
39. Laughlin MJ, Barker J, Bambach B, et al (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815
40. Margolis DA, Casper JT (1999) Allogeneic transplantation for acute myeloid leukemia in children. In Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation. Blackwell, London, pp 835-848
41. Marmont AM, Horowitz MM, Gale RP, et al (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120
42. Mencacci A, Perruccio K, Bacci A, et al (2001) Defective antifungal T helper (TH) 1 immunity in a murine model of allogeneic T cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood 97:1483
43. Mickelson EM, Petersdorf EW, Hansen JA. (2002) HLA matching and hematopoietic cell transplant outcome. Clin Transpl 2002:263
44. Min D, Taylor PA, Panoskaltsis-Mortari A, et al (2000) Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 99:4592
45. Moretta A, Moretta L (1987) HLA class I specific inhibitory receptors. Curr Opin Immunol 9:694
46. Muller S, Schulz A, Reiss U, et al (1999) Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children. Bone Marrow Transplant. 24:575
47. Ocks L, Shu XO, Miller J, et al (1995) Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979
48. O'Reilly RJ, Collins NH, Brochstein J, et al (1986) Soybean lectin agglutination and E-rosette depletion for removal of T-cells from HLA-identical marrow grafts: results in 60 consecutive patients transplanted for hematological malignancy. In Hagenbeek A, Löwenberg B (eds) Minimal residual disease in acute leukemia. Martinus Nijhoff, Dordrecht, pp 337-344
49. Ottinger HD, Ferencik S, Beelen DW, et al (2003) Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 102:1131
50. Pan L, Delmonte J Jr, Jalonen CK, et al (1995) Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422
51. Papadopoulos E, Carabasi MH, Castro-Malaspina H, et al (1998) T-cell-depleted allogeneic bone marrow transplantation as post-remission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft versus host disease. Blood 91:1083
52. Perruccio K, Tosti A, Posati S, et al (2000) Transfer of functional immune responses to aspergillus and CMV after haploidentical hematopoietic transplantation. Blood 96:2383
53. Rachamin N, Gan J, Segall R, et al (1998) Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 65:1386
54. Reisner Y, Kapoor N, Kirkpatrick D, et al (1983) Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341
55. Reisner Y, Ben-Bassat I, Douer D, et al (1986) Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation. Proc Natl Acad Sci USA 83:4012
56. Reisner Y, Martelli MF (1995) Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 16:437
57. Ringden O, Nilsson B (1985) Death by graft-versus-host disease associated with HLA-mismatch, high recipient age, low marrow cell dose, and splenectomy. Transplantation 40:39
58. Rowe JM (2001) Current standard therapy of adult acute myeloid leukemia. Hematology 2001 Education Program Book. American Society of Hematology, Washington, pp 62-68
59. Ruggeri L, Capanni M, Casucci M, et al (1999) Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94:333
60. Ruggeri L, Capanni M, Urbani E, et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097
61. Sallusto F, Lenig D, Forster R, et al (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708
62. Sanz MA, Sanz GF (2002) Unrelated donor umbilical cord blood transplantation in adults. Leukemia 16:1984
63. Schwartz E, Lapidot T, Gozes D, et al (1987) Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors. J Immunol 138:460
64. Sierra J, Storer B, Hansen JA, et al (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 89:4226
65. Sierra J, Storer B, Hansen JA, et al (2000) Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 26:397
66. Small TN, Papadopoulos EB, Boulad F, et al (1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 93:467
67. + T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Biol Blood Marrow Transplant 3:11
68. Stockerl-Goldstein KE, Blume KG (1999) Allogeneic hematopoietic cell transplantation for adult patients with acute myeloid leukemia. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation. Blackwell, London, pp 823-834
69. Terenzi A, Lubin I, Lapidot T, et al (1990) Enhancement of T-cell-depleted bone marrow allografts in mice by thiotepa. Transplantation 50:717
70. Terenzi A, Aristei C, Aversa F, et al (1996) Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results. Transplant Proc 28:3101
71. Van Agthoven M, Groot MT, Verdonck LF, et al (2002) Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. Bone Marrow Transplant 30:243
72. Velardi A, Ruggeri L, Capanni M, et al (2003) Impact of NK cell alloreactivity on mismatched hematopoietic transplantation: an update on donor selection criteria and on transplantation outcomes. Blood Abstract book ASH 2003. American Society of Hematology, Washington, p 527
73. Volpi I, Perruccio K, Tosti A, et al (2001) Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants. Blood 97:2514